Home > Patient Support

Patient Support and Resources

TODO Resources to help eligible patients access
TAZVERIK® (tazemetostat)

Download a digital copy of the
TAZVERIK Patient Brochure.

Download

Download a copy of the
EpizymeNOW patient enrollment form to
complete with your healthcare provider. Terms and conditions apply.

Download

TODO EpizymeNOW Patient & Product Support programs

Quick Start
Program

You may be eligible to receive your medication right away if you experience a delay in the authorization of prescription drug coverage greater than five business days, and if your doctor has determined there is an immediate medical need to start treatment with TAZVERIK.

Bridge Supply
Program

You may be eligible to receive a limited supply of free medication if you experience an unexpected change or disruption in your prescription drug coverage or supply (e.g., your insurance provider requires a new or updated prior authorization or a change or loss of insurance).

Patient Assistance
Program (PAP)

You may be eligible to receive free medication if you are uninsured, underinsured (based on program eligibility criteria), or are enrolled in the Medicare Part D benefit and have coverage for TAZVERIK, but are currently experiencing financial hardship (based on Epizyme’s review of appropriate supporting documentation).

Co-Pay Assistance
Program

For patients with commercial (private) health insurance, you may be eligible to receive co‑payment assistance to help reduce your out‑of‑pocket costs for Epizyme medications.

This offer is not valid for cash‑paying patients or patients currently enrolled in Medicare, Medicaid, or any other federal or state healthcare program. Limitations apply. Void where prohibited.

Eligibility Criteria

Quick Start
& Bridge Supply
PAP
Co-Pay
You have prescription drug coverage either under a commercial (private) health plan or a government program, including Medicare or Medicaid, and you are actively pursuing initial coverage or reauthorization of coverage for TAZVERIK.
You meet Epizyme’s financial eligibility requirements for enrollment in the Patient Assistance Program based on income and other supporting financial documentation.
You currently have commercial (private) health insurance that covers TAZVERIK and no primary or secondary insurance coverage under any state or federal healthcare program, including Medicare or Medicaid.
U.S. residency (including U.S. territories)
You have a valid prescription for TAZVERIK
  • Your insurance coverage for TAZVERIK is delayed for more than five business days, and your doctor has determined there is an immediate medical need to start treatment with TAZVERIK.
  • If eligible, your 15-day supply (up to 60 days) of TAZVERIK will be provided to you until your prior authorization or coverage request for TAZVERIK is approved.
You are currently uninsured or underinsured based on insurance information verification by Epizyme.
 
Quick Start
& Bridge Supply
You have prescription drug coverage either under a commercial (private) health plan or a government program, including Medicare or Medicaid, and you are actively pursuing initial coverage or reauthorization of coverage for TAZVERIK.
  • U.S. residency (including U.S. territories)
  • You have a valid prescription for TAZVERIK
  • Your insurance coverage for TAZVERIK is delayed for more than five business days, and your doctor has determined there is an immediate medical need to start treatment with TAZVERIK.
  • If eligible, your 15-day supply (up to 60 days) of TAZVERIK will be provided to you until your prior authorization or coverage request for TAZVERIK is approved.
PAP
You meet Epizyme’s financial eligibility requirements for enrollment in the Patient Assistance Program based on income and other supporting financial documentation.
  • U.S. residency (including U.S. territories)
  • You have a valid prescription for TAZVERIK
  • You are currently uninsured or underinsured based on insurance information verification by Epizyme.
Co-Pay
You currently have commercial (private) health insurance that covers TAZVERIK and no primary or secondary insurance coverage under any state or federal healthcare program, including Medicare or Medicaid.
  • U.S. residency (including U.S. territories)
  • You have a valid prescription for TAZVERIK

Disclaimer: All patient support is subject to eligibility criteria and program terms and conditions.

Ongoing support from EpizymeNOW

If you are interested in learning more about any of the services mentioned above, ask your doctor for more information or contact EpizymeNOW Patient & Product Support at 1-833-4EPINOW (437-4669), Monday through Friday (9 AM - 6 PM ET).

TODO Additional follicular lymphoma resources

While your healthcare team can provide support throughout your FL journey, there are other organizations and communities that may be able to help.

CancerCare

cancercare.org

1-800‑813‑HOPE (4673)

The Leukemia & Lymphoma Society (LLS)

LLS.org

1-800-955-4572

Lymphoma Research Foundation (LRF)

lymphoma.org

1-800-500-9976

Learn more about recommended dosing and  how  to  take  TAZVERIK.
<Dosing & administration
Indication and Important Safety Information

INDICATION

What is TAZVERIK?

TAZVERIK is a prescription medicine used to treat:

The approval of TAZVERIK in these patients is based on a study that measured the percentage of patients whose tumor shrank or disappeared after treatment and how long that response lasted. TAZVERIK is still being studied to confirm these benefits.

It is not known if TAZVERIK is safe and effective in children less than 16 years of age.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about TAZVERIK?

TAZVERIK can cause serious side effects, including:
Before taking TAZVERIK tell your healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TAZVERIK may affect the way other medicines work and other medicines may affect how TAZVERIK works.

What should I avoid while taking TAZVERIK?

Talk to your healthcare provider before starting any new medications or supplements.

What are the possible side effects of TAZVERIK?

The most common side effects of TAZVERIK in people with follicular lymphoma include:

These are not all the possible side effects of TAZVERIK.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please read the full Prescribing Information, including Medication Guide for TAZVERIK, and discuss it with your doctor.